News

A federal judge in Texas Aug. 23 blocked the Biden Administration from enforcing new guidance related to the Emergency Medical Treatment and Active Labor Act, which it issued following the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization. The judge held the Department of Health and Human Services’ guidance does not preempt state law, exceeds the authority of EMTALA, and was improperly issued without notice and comment.

Pfizer yesterday announced its application for an emergency use authorization for a COVID-19 vaccine booster that is designed to protect against the SARS-CoV-2 omicron variant. The booster is meant for the 12 and older age group.

The U.S. Department of Health and Human Services on Monday awarded $25 million in planning grants to expand access to home and community-based services through Medicaid’s Money Follows the Person program.

The Departments of Health and Human Services, Labor and the Treasury last week issued final regulations pertaining to several provisions of the No Surprises Act. In addition, the departments released a series of resources related to the regulations.

The AHA, in a letter today to the Centers for Medicare & Medicaid Services, cautioned against softening standards designed to maintain the safety and quality of laboratory testing in the U.S., including those regulating the professionals who staff the nation’s Clinical Laboratory Improvement Amendments-certified labs.

The Centers for Medicare & Medicaid Services today issued an informational bulletin urging states to use existing Medicaid authority to drive better health outcomes for nursing home residents and improve staff pay, training and retention.

AHA today launched the Stress Meter (TM), a hub of curated, vetted resources featuring stress-relief information and techniques. Though not a diagnostic tool, the Stress Meter functions as a way for users to take a moment and evaluate their current stress level — mild, moderate or severe — and then access publicly available resources for understanding appropriate next steps.

Novavax today announced the Food and Drug Administration expanded the emergency use authorization for its Adjuvanted (NVX-CoV2373) COVID-19 vaccine. Under the expanded EUA, the two-dose primary series can be administered for adolescents between the ages of 12 and 17.

On this episode, I talk with Julie Yaroch, D.O., president of ProMedica Charles and Virginia Hickman Hospital in Adrian, Mich. Julie and I talk about the issues that rural hospitals face, including workforce shortages, increased costs of care, and an aging population.

The Departments of Health and Human Services, Labor, and the Treasury late today issued a final rule updating several key regulations pertaining to the No Surprises Act, including what information certified independent dispute resolution entities (IDREs) must consider when making a payment determination under the federal arbitration process. According to the departments, these changes were made to conform with February and July 2022 rulings by the U.S. District Court for the Eastern District of Texas.

Chethan Sathya, M.D., a pediatric trauma surgeon and director of Northwell Health's Center for Gun Violence Research, talks with Laura Castellanos, associate director of AHA’s Hospitals Against Violence initiative, about the cost of gun violence to hospitals and health systems as they treat a growing number of victims.

The Centers for Medicare & Medicaid Services yesterday proposed requiring states to report certain quality measures for children, adults and home health services in Medicaid and the Children’s Health Insurance Program beginning in federal fiscal year 2024. Currently, states may choose not to report the measures.

U.S.-based Grand River Aseptic Manufacturing will fill and finish 2.5 million of the 5.5 million vials of JYNNEOS monkeypox vaccine ordered by the Department of Health and Human Services to make available to individuals at high risk for the virus.

The Centers for Medicare & Medicaid Services yesterday released fact sheets summarizing the current status of Medicare COVID-19 blanket waivers and flexibilities by provider type, as well as flexibilities applicable to the Medicaid community. The fact sheets include information about which waivers and flexibilities have already been terminated, have been made permanent or will end at the end of the COVID-19 public health emergency.

Congress has headed home for its traditional August recess. That tradition began, by the way, as a sensible concession to Washington, D.C.’s steamy summer climate, long before central air conditioning came to Capitol Hill in 1938.

Stacy Bank, M.D., medical director of University of Utah Health’s Intensive Outpatient Clinic, and Chad Westover, CEO of University of Utah Health Plans, discuss how they’re providing wraparound medical and social care to some of the health system’s most at-risk patients.

Jurisdictions that have used 90% of their JYNNEOS monkeypox vaccine supply and are administering the vaccine intradermally to adults can begin ordering additional vaccine Monday, when the Department of Health and Human Services will release an additional 11.8 million doses to administer to high-risk individuals, the White House announced today.

In mid-December, hospitals will transition to reporting COVID-19 data via the Centers for Disease Control and Prevention’s National Healthcare Safety Network, which will assume responsibility for collecting the data when the Department of Health and Human Services’ contract with TeleTracking expires Dec. 31. CDC will host a series of training webinars on the transition beginning Aug. 23.

The Department of Health and Human Services Monday began accepting orders from states and other jurisdictions for a portion of 442,000 additional doses of the JYNNEOS monkeypox vaccine. To stretch available doses up to five fold, the Food and Drug Administration last week issued an emergency use authorization allowing health care providers to administer the vaccine intradermally to adults.

The U.S. District Court for the District of Columbia should vacate the 2022 outpatient prospective payment system rule insofar as it sets a payment rate for 340B hospitals that is lower than the generally applicable payment rate of Average Sales Price plus 6%, AHA told the court yesterday.